LIN:NASDAQ
Linde plc
Data as of 2026-03-09 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Linde plc (LIN) is trading at $483.62, comfortably above its 50‑day (≈$461.56) and 200‑day (≈$456.13) moving averages, but slightly under the 20‑day SMA (≈$488.90), indicating a short‑term pullback within a longer‑term bullish framework. The RSI sits at 51, suggesting neutral momentum, while the MACD histogram is negative and the signal line is deemed bearish, warning of possible near‑term downside pressure. Volatility over the past 30 days is elevated at roughly 21%, yet the stock’s beta of 0.58 points to lower systematic risk compared with the market. Recent earnings beat (adjusted EPS $4.20 vs. $4.18 consensus) and a 6% YoY revenue rise to $8.8 B underscore solid operational performance, but the full‑year 2026 guidance fell short of analyst expectations, prompting a modest pre‑market dip of over 2%. The DCF‑derived fair value of $134 suggests a stark undervaluation, yet market multiples (PE 33×, forward PE 24.8×, P/B 5.86×) are on the higher side, resulting in a modest upside estimate of ~6% from current levels. The dividend yield of 1.32% with a 41% payout ratio is supported by robust cash generation (free cash flow $4.79 B) and a strong balance sheet, indicating sustainability. Overall, the stock sits near a support zone around $444 and faces resistance near $511, with the technical picture mixed but fundamentals indicating a resilient, dividend‑paying growth blend.
Trading Recommendations
Short Term
< 1 yearKey Factors
- Guidance miss leading to recent price dip
- Bearish MACD signal
- Price hovering just below 20‑day SMA
Medium Term
1–3 yearsKey Factors
- Consistent revenue and margin expansion
- Modest upside potential (~6%) relative to current price
- Sustainable dividend with strong cash flow
Long Term
> 3 yearsKey Factors
- Global footprint across diversified end‑markets
- Stable earnings and cash generation
- Attractive dividend yield and low beta
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.